title: [A case of therapy-related acute myeloid leukemia associated with inv(16)].
abstract: The inv(16)(p13q22) is found in de novo AML and is closely associated with the FAB subtype M4eo. The inv(16) is rarely reported in therapy-related AML (t-AML) patients. Herein, we report a case of t-AML with inv(16) after combination chemotherapy using antimitotic agent and alkylating agent (cis-platin-paclitaxel) for ovarian serous cystadenocarcinoma.
authors: Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
authors: So-Young
authors: SY
authors: Lee
authors: Myungshin
authors: M
authors: Kim
authors: Jihyang
authors: J
authors: Lim
authors: Yonggoo
authors: Y
authors: Kim
authors: Kyungja
authors: K
authors: Han
authors: Sung Yong
authors: SY
authors: Kim
authors: Hee Je
authors: HJ
authors: Kim
authors: In-Yang
authors: IY
authors: Park
mesh_terms: D050256:Antimitotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D007446:Chromosome Inversion; D002885:Chromosomes, Human, Pair 16 / Q000235:genetics*; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D017239:Paclitaxel; D043823:Taxoids / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D050256:Antimitotic Agents; D043823:Taxoids; D017239:Paclitaxel; D002945:Cisplatin